Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2019, Cilt: 41 Sayı: 2, 357 - 362, 30.06.2019

Gülhan Koşucu , Sefa Levent Özşahin Ömer Tamer Doğan Neslihan Taş

https://doi.org/10.7197/223.vi.541988

Öz

Kaynakça

  • 1. Depalo VA, Mccool D. Evaluation of the patient with pulmonary disease. The History & Physical Examination in Pulmonary Medicine. In: Hanley M, Welsh C, Diagnosis & Treatment in pulmonary medicine. New York: Lange Medical Books/McGraw Hill;16-25, 2003.
  • 2. Ünsal E, Köksal D, Çimen F, Hoca NT, Şipit T. Analysis of patients with hemoptysis in a reference hospital for chest diseases. Tüberküloz ve Toraks Dergisi;54(1):34-42, 2006.
  • 3. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/ bronchoscopic correlation. Chest; 105: 1155-62, 1994.
  • 4. Çelik P, Gönlügür U, Akın M, Orman A. Hemoptizili Olgularımızın Analizi [Analysis of Cases with Hemoptysis]. Heybeliada Tıp Bülteni; 3: 45-8, 1997.
  • 5. Özgül MA, Turna A, Yıldız P, Ertan E, Kahraman S, Yilmaz V. Risk factors and recurrence patterns in 203 patients with hemoptysis. Tüberküloz ve Toraks Dergisi; 54: 243-8, 2006.
  • 6. Doğan ÖT, Berk S,Engin A, Akkurt İ. Hemoptizide etyolojik faktörler [Etiological factors in hemoptysis]. Cumhuriyet Tıp Dergisi;32: 48-53, 2010.
  • 7. Koca H, Özden ŞS, Güldaval F, Özacar R. Hemoptizi: 311 Olguluk bir Retrospektif Analiz [Hemoptysis: A Retrospective Analysis of 311 Cases]. İzmir Göğüs Hastanesi Dergisi; 22(3): 65-6, 2008.
  • 8. Ataç G, Erdem İ, Saraç S, Öztaş S, Köklü S, Tümer Ö, Kurutepe M. Göğüs Hastalıkları Referans Hastanesindeki 61 Hemoptizili Hastanın Retrospektif İncelenmesi [Retrospective Examination of 61 Patients with Hemoptysis in a Reference Hospital for Chest Diseases]. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi; 48(3):165-170, 2008.
  • 9. Arslan S, Çimen P, Tekgül S, Güren E, Yalnız E, Özden EP. Hemoptizili olgularda etiyoloji ve akciğer grafisi, bilgisayarlı tomografi (BT), fiberoptik bronkoskopi (FOB) bulgularının değerlendirilmesi [Evaluation of etiology and results of chest x-ray, computed tomography (CT), and fiberoptic bronchoscopy (FOB) in cases with hemoptysis]. İzmir Göğüs Hastanesi Dergisi;19(3): 93-100, 2005.
  • 10. Pisters K, Ginsberg R, Giroux D, Kris M, Putnam JB, Roberts JR et al. Bimodality lung oncology team (BLOT) trial of induction paclitaxel/carboplatin in early stage
  • non-small cell lung cancer (NSCLC): Long term follow-up of a phase II trial. Proc Am Soc Clin Oncol 22: 633 (abstract 2544), 2003.
  • 11. Field JK. Selection and validation of new lung cancer markers for the molecular pathological assessment of individuals with a high risk of developing lung cancer. In: Brambilla C, Brambilla E. (Editors). Lung tumors fundamental biology and clinical management. New York: Marcel Dekker Inc: 287-302, 1999.
  • 12. Global Initiative For Chronic Obstructive Lung Disease. Global Strategy For The Diagnosis, management, And Prevention Of Chronic Obstructive Pulmonary Disease (GOLD). Update 2006.
  • 13. Behera D, Balamugesh T. Indoor air pollution as a risk factor for lung cancer in women. J Assoc Physicians India; 53: 190-2, 2005
  • 14. Gani H, Seyfkli Z, Çelik VK, Akkurt İ. Abadoğlu Ö. Kırsal alanlardaki kadınlarda biomass maruziyetinin lipid peroksidasyon ve antioksidan enzim aktivitelerine etkileri [Effects of biomass exposure on lipid peroxidation and antioxidant enzyme activities in women in rural areas]. Toraks Dergisi; 1:13-18, 2000.
  • 15. Arslan S, Çimen P, Tekgül S, Güren E, Yalnız E, Özden EP. Hemoptizili olgularda etiyoloji ve akciğer grafisi, bilgisayarlı tomografi (BT), fiberoptik bronkoskopi (FOB) bulgularının değerlendirilmesi [Evaluation of etiology and results of chest x-ray, computed tomography (CT), and fiberoptic bronchoscopy (FOB) in cases with hemoptysis]. İzmir Göğüs Hastanesi Dergisi;19(3): 93-100, 2005.
  • 16. Johnston H, Reisz G. Chancing spectrum of hemoptysis: underlying causes in 148 patients undergoing diagnostic fiberoptic bronchoscopy. Arch Intern Med; 149:1661-8, 1989
  • 17. Yavaşoğlu G, Karalar S, Balcıoğlu İ. Hemoptizili olguların retrospektif değerlendirilmesi [Retrospective evaluation of cases with hemoptysis]. TUSAD XXIII. Kongre Kitabı; 20: 583-6, 1996.
  • 18. Fidan A, Özdoğan S, Oruç O, Salepçi B, Öcal Z, Çağlayan B. Hemoptysis: a retrospective analysis of 108 cases. Respir Med; 96:677-80, 2002.
  • 19. Sevim T, Ataç G, Ongen A, Özmen İ, Kapaklı N, Horzum G et al. Yirmibeş polmoner emboli olgusunun değerlendirilmesi [Evaluation of twenty-five cases of pulmonary embolism]. Solunum Hastalıkları; 12: 39-43, 2001.
  • 20. Santiago S, Tobias J, William AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med; 151: 2449-51, 1991.
  • 21. Seki N, Shiozaki G, Ota M. Risk factors for a second episode of hemoptysis. Clinical Medicine Insights: Circulatory Respiratory and Pulmonary Medicine; 3:1-7, 2009.
  • 22. Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: Etiology, evaluation, and outcome in a tertiary referral hospital. Chest; 112:440-444, 1997.

A five-year analysis of patients with hemoptysis admitted to the pulmonary diseases clinic of Cumhuriyet University Hospital

Yıl 2019, Cilt: 41 Sayı: 2, 357 - 362, 30.06.2019

Gülhan Koşucu , Sefa Levent Özşahin Ömer Tamer Doğan Neslihan Taş

https://doi.org/10.7197/223.vi.541988

Öz

This study aimed to identify the most common causes of hemoptysis and the
methods utilized for the diagnosis, to determine the relationship between the
etiological factors and the amount of hemoptysis, to establish the association
between exposures and hemoptysis, and to reveal other possible factors related to hemoptysis in patients admitted to our clinic due to hemoptysis between January 2005 and
December 2009. Thus, 385 cases were evaluated retrospectively. The most common
causes of hemoptysis in the whole study population were identified as
pneumonia, lung cancer and, pulmonary thromboembolism (33%, 14.8 and 14.0%,
respectively). A stepwise
approach including clinical and laboratory techniques, radiological methods,
fiberoptic bronchoscopy, and echocardiograpy enhances the diagnosis of hemoptysis.

Anahtar Kelimeler

Keywords: Etiology hemoptysis lung cancer

Kaynakça

  • 1. Depalo VA, Mccool D. Evaluation of the patient with pulmonary disease. The History & Physical Examination in Pulmonary Medicine. In: Hanley M, Welsh C, Diagnosis & Treatment in pulmonary medicine. New York: Lange Medical Books/McGraw Hill;16-25, 2003.
  • 2. Ünsal E, Köksal D, Çimen F, Hoca NT, Şipit T. Analysis of patients with hemoptysis in a reference hospital for chest diseases. Tüberküloz ve Toraks Dergisi;54(1):34-42, 2006.
  • 3. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/ bronchoscopic correlation. Chest; 105: 1155-62, 1994.
  • 4. Çelik P, Gönlügür U, Akın M, Orman A. Hemoptizili Olgularımızın Analizi [Analysis of Cases with Hemoptysis]. Heybeliada Tıp Bülteni; 3: 45-8, 1997.
  • 5. Özgül MA, Turna A, Yıldız P, Ertan E, Kahraman S, Yilmaz V. Risk factors and recurrence patterns in 203 patients with hemoptysis. Tüberküloz ve Toraks Dergisi; 54: 243-8, 2006.
  • 6. Doğan ÖT, Berk S,Engin A, Akkurt İ. Hemoptizide etyolojik faktörler [Etiological factors in hemoptysis]. Cumhuriyet Tıp Dergisi;32: 48-53, 2010.
  • 7. Koca H, Özden ŞS, Güldaval F, Özacar R. Hemoptizi: 311 Olguluk bir Retrospektif Analiz [Hemoptysis: A Retrospective Analysis of 311 Cases]. İzmir Göğüs Hastanesi Dergisi; 22(3): 65-6, 2008.
  • 8. Ataç G, Erdem İ, Saraç S, Öztaş S, Köklü S, Tümer Ö, Kurutepe M. Göğüs Hastalıkları Referans Hastanesindeki 61 Hemoptizili Hastanın Retrospektif İncelenmesi [Retrospective Examination of 61 Patients with Hemoptysis in a Reference Hospital for Chest Diseases]. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi; 48(3):165-170, 2008.
  • 9. Arslan S, Çimen P, Tekgül S, Güren E, Yalnız E, Özden EP. Hemoptizili olgularda etiyoloji ve akciğer grafisi, bilgisayarlı tomografi (BT), fiberoptik bronkoskopi (FOB) bulgularının değerlendirilmesi [Evaluation of etiology and results of chest x-ray, computed tomography (CT), and fiberoptic bronchoscopy (FOB) in cases with hemoptysis]. İzmir Göğüs Hastanesi Dergisi;19(3): 93-100, 2005.
  • 10. Pisters K, Ginsberg R, Giroux D, Kris M, Putnam JB, Roberts JR et al. Bimodality lung oncology team (BLOT) trial of induction paclitaxel/carboplatin in early stage
  • non-small cell lung cancer (NSCLC): Long term follow-up of a phase II trial. Proc Am Soc Clin Oncol 22: 633 (abstract 2544), 2003.
  • 11. Field JK. Selection and validation of new lung cancer markers for the molecular pathological assessment of individuals with a high risk of developing lung cancer. In: Brambilla C, Brambilla E. (Editors). Lung tumors fundamental biology and clinical management. New York: Marcel Dekker Inc: 287-302, 1999.
  • 12. Global Initiative For Chronic Obstructive Lung Disease. Global Strategy For The Diagnosis, management, And Prevention Of Chronic Obstructive Pulmonary Disease (GOLD). Update 2006.
  • 13. Behera D, Balamugesh T. Indoor air pollution as a risk factor for lung cancer in women. J Assoc Physicians India; 53: 190-2, 2005
  • 14. Gani H, Seyfkli Z, Çelik VK, Akkurt İ. Abadoğlu Ö. Kırsal alanlardaki kadınlarda biomass maruziyetinin lipid peroksidasyon ve antioksidan enzim aktivitelerine etkileri [Effects of biomass exposure on lipid peroxidation and antioxidant enzyme activities in women in rural areas]. Toraks Dergisi; 1:13-18, 2000.
  • 15. Arslan S, Çimen P, Tekgül S, Güren E, Yalnız E, Özden EP. Hemoptizili olgularda etiyoloji ve akciğer grafisi, bilgisayarlı tomografi (BT), fiberoptik bronkoskopi (FOB) bulgularının değerlendirilmesi [Evaluation of etiology and results of chest x-ray, computed tomography (CT), and fiberoptic bronchoscopy (FOB) in cases with hemoptysis]. İzmir Göğüs Hastanesi Dergisi;19(3): 93-100, 2005.
  • 16. Johnston H, Reisz G. Chancing spectrum of hemoptysis: underlying causes in 148 patients undergoing diagnostic fiberoptic bronchoscopy. Arch Intern Med; 149:1661-8, 1989
  • 17. Yavaşoğlu G, Karalar S, Balcıoğlu İ. Hemoptizili olguların retrospektif değerlendirilmesi [Retrospective evaluation of cases with hemoptysis]. TUSAD XXIII. Kongre Kitabı; 20: 583-6, 1996.
  • 18. Fidan A, Özdoğan S, Oruç O, Salepçi B, Öcal Z, Çağlayan B. Hemoptysis: a retrospective analysis of 108 cases. Respir Med; 96:677-80, 2002.
  • 19. Sevim T, Ataç G, Ongen A, Özmen İ, Kapaklı N, Horzum G et al. Yirmibeş polmoner emboli olgusunun değerlendirilmesi [Evaluation of twenty-five cases of pulmonary embolism]. Solunum Hastalıkları; 12: 39-43, 2001.
  • 20. Santiago S, Tobias J, William AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med; 151: 2449-51, 1991.
  • 21. Seki N, Shiozaki G, Ota M. Risk factors for a second episode of hemoptysis. Clinical Medicine Insights: Circulatory Respiratory and Pulmonary Medicine; 3:1-7, 2009.
  • 22. Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: Etiology, evaluation, and outcome in a tertiary referral hospital. Chest; 112:440-444, 1997.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Medical Science Research Makaleler
Yazarlar

Gülhan Koşucu 0000-0003-2881-9360

Sefa Levent Özşahin

Ömer Tamer Doğan

Neslihan Taş

Yayımlanma Tarihi 30 Haziran 2019
Kabul Tarihi 27 Haziran 2019
Yayımlandığı Sayı Yıl 2019Cilt: 41 Sayı: 2

Kaynak Göster

AMA Koşucu G, Levent Özşahin S, Doğan ÖT, Taş N. A five-year analysis of patients with hemoptysis admitted to the pulmonary diseases clinic of Cumhuriyet University Hospital. CMJ. Haziran 2019;41(2):357-362. doi:10.7197/223.vi.541988